EOSINOPHILIC ASTHMA
Clinical trials for EOSINOPHILIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ASTHMA trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could ease severe asthma attacks
Disease control OngoingThis study tests an oral drug called dexpramipexole in 600 people with eosinophilic asthma, a type of asthma linked to high levels of certain white blood cells. Participants take the drug or a placebo daily for 24 weeks alongside their usual asthma medications. The goal is to see…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Proteomics may reveal hidden clues to rare disease treatment success
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to identify proteins in blood, saliva, and sputum that can help doctors predict organ damage and how well patients with EGPA (a rare inflammatory disease) or severe asthma respond to the drug mepolizumab. Researchers will analyze samples from 90 participants befor…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE4 • Sponsor: Azienda Ospedaliero Universitaria di Cagliari • Aim: Knowledge-focused
Last updated May 26, 2026 11:22 UTC